Content about Nycomed

August 2, 2011

In line with its new position as a stand-alone corporation, the former U.S. subsidiary of a Swiss drug maker has appointed a new leader.

June 22, 2011

Impax Labs has expanded its senior management team with two appointments.

May 12, 2011

Japan-based Takeda Pharmaceutical may acquire Switzerland’s Nycomed for $12 billion, according to published reports.

May 11, 2011

Drug maker Perrigo has reached a licensing agreement with Nycomed US that will allow it to launch a generic treatment for dermatitis in 2012, the company said.

March 4, 2011

SUPPLIER NEWS — Impax Labs received regulatory approval from the Food and Drug Administration for its generic version of a bacterial infection treatment. The drug maker said the FDA approved its 150-mg doxycycline monohydrate capsules, a drug used to treat bacterial infections and a generic version of Adoxa, made by Nycomed subsidiary PharmaDerm. The 150-mg strength of Adoxa had sales of about $25 million during the 12 months ended in December 2010, according to Wolters Kluwer.

February 18, 2011

A generic drug maker received regulatory approval from the Food and Drug Administration for its generic version of a bacterial infection treatment.

July 18, 2010

A U.S. District Court has ruled in favor of two companies who alleged patent infringement...

© 2014 Drug Store News. All Rights Reserved.